FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022098162> ?p ?o ?g. }

• W2022098162 endingPage "352" @default.
• W2022098162 startingPage "345" @default.
• W2022098162 abstract "Recent randomised studies have reported that single fraction radiotherapy is as effective as multifraction radiotherapy in relieving pain caused by bone metastasis. However, there are concerns about the higher re-treatment rates and the efficacy of preventing future complications, such as pathological fracture and spinal cord compression, by single fraction radiotherapy. A systematic review of randomised studies, examining the effectiveness of single fraction radiotherapy versus multiple fraction radiotherapy for metastatic bone pain relief and prevention of bone complications, was conducted to help answer this controversy. Randomised studies comparing single fraction radiotherapy with multifraction radiotherapy on metastatic bone pain were identified. The analyses were performed using intention-to-treat principle. The results were pooled using meta-analysis to estimate the effect of treatment on pain response, re-treatment rate, pathological fracture rate and spinal cord compression rate. Twelve trials involving 3621 sites were included in the meta-analysis. The overall pain-response rates for single fraction radiotherapy and multifraction radiotherapy were 60% (1080/1814) and 59% (1060/1807), respectively, giving an odds ratio (OR) of 1.03 (95% confidence interval [CI] 0.90-1.19), indicating no difference between the two radiotherapy schedules. There was also no difference in complete pain response rates for single fraction radiotherapy (34% [508/1476]) and multifraction radiotherapy (32% [475/1473]), with an OR of 1.10 (950% CI 0.94-1.30). Patients treated by single fraction radiotherapy had a higher re-treatment rate, with 21.5% (267/1240) requiring re-treatment compared with 7.4% (91/1236) of patients in the multifraction radiotherapy arm (OR 3.44 [95% CI 2.67-4.43]). The pathological fracture rate was also higher in single fraction radiotherapy arm patients. Three per cent (37/1240) of patients treated by single fraction radiotherapy developed pathological fracture compared with 1.6% (20/1236) for those treated by multifraction radiotherapy (OR 1.82 [95% CI 1.06-3.11]). The spinal cord compression rates were similar for both arms (OR 1.41 [95% CI 0.72-2.75]). Single fraction radiotherapy was as effective as multifraction radiotherapy in relieving metastatic bone pain. However, the re-treatment rate and pathological fracture rate were higher after single fraction radiotherapy. Studies with quality of life and health economic end points are warranted to find out the optimal treatment option." @default.
• W2022098162 created "2016-06-24" @default.
• W2022098162 creator A5014903338 @default.
• W2022098162 creator A5029269873 @default.
• W2022098162 creator A5032518609 @default.
• W2022098162 creator A5042516416 @default.
• W2022098162 creator A5043350291 @default.
• W2022098162 date "2003-09-01" @default.
• W2022098162 modified "2023-10-09" @default.
• W2022098162 title "Palliation of Metastatic Bone Pain: Single Fraction versus Multifraction Radiotherapy – A Systematic Review of Randomised Trials" @default.
• W2022098162 cites W1967568802 @default.
• W2022098162 cites W1970944786 @default.
• W2022098162 cites W1971021347 @default.
• W2022098162 cites W1974850826 @default.
• W2022098162 cites W1982136835 @default.
• W2022098162 cites W1986215651 @default.
• W2022098162 cites W1989098069 @default.
• W2022098162 cites W1990718568 @default.
• W2022098162 cites W1995140356 @default.
• W2022098162 cites W1998066564 @default.
• W2022098162 cites W1998887983 @default.
• W2022098162 cites W1999978652 @default.
• W2022098162 cites W2000016107 @default.
• W2022098162 cites W2003786866 @default.
• W2022098162 cites W2009700462 @default.
• W2022098162 cites W2015669671 @default.
• W2022098162 cites W2023141374 @default.
• W2022098162 cites W2030974023 @default.
• W2022098162 cites W2031145335 @default.
• W2022098162 cites W2034372472 @default.
• W2022098162 cites W2036541203 @default.
• W2022098162 cites W2041568526 @default.
• W2022098162 cites W2044763202 @default.
• W2022098162 cites W2047842438 @default.
• W2022098162 cites W2065272001 @default.
• W2022098162 cites W2066553392 @default.
• W2022098162 cites W2068051883 @default.
• W2022098162 cites W2072631690 @default.
• W2022098162 cites W2073838058 @default.
• W2022098162 cites W2078574113 @default.
• W2022098162 cites W2080661941 @default.
• W2022098162 cites W2089009335 @default.
• W2022098162 cites W2091150004 @default.
• W2022098162 cites W2107328434 @default.
• W2022098162 cites W2108145085 @default.
• W2022098162 cites W2114360374 @default.
• W2022098162 cites W2116617292 @default.
• W2022098162 cites W2122244986 @default.
• W2022098162 cites W2126121630 @default.
• W2022098162 cites W2126697292 @default.
• W2022098162 cites W2128443828 @default.
• W2022098162 cites W2136392842 @default.
• W2022098162 cites W2143745561 @default.
• W2022098162 cites W2165747307 @default.
• W2022098162 cites W2334960966 @default.
• W2022098162 cites W2402315553 @default.
• W2022098162 cites W2443131774 @default.
• W2022098162 cites W2471904951 @default.
• W2022098162 doi "https://doi.org/10.1016/s0936-6555(03)00113-4" @default.
• W2022098162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14524489" @default.
• W2022098162 hasPublicationYear "2003" @default.
• W2022098162 type Work @default.
• W2022098162 sameAs 2022098162 @default.
• W2022098162 citedByCount "292" @default.
• W2022098162 countsByYear W20220981622012 @default.
• W2022098162 countsByYear W20220981622013 @default.
• W2022098162 countsByYear W20220981622014 @default.
• W2022098162 countsByYear W20220981622015 @default.
• W2022098162 countsByYear W20220981622016 @default.
• W2022098162 countsByYear W20220981622017 @default.
• W2022098162 countsByYear W20220981622018 @default.
• W2022098162 countsByYear W20220981622019 @default.
• W2022098162 countsByYear W20220981622020 @default.
• W2022098162 countsByYear W20220981622021 @default.
• W2022098162 countsByYear W20220981622022 @default.
• W2022098162 countsByYear W20220981622023 @default.
• W2022098162 crossrefType "journal-article" @default.
• W2022098162 hasAuthorship W2022098162A5014903338 @default.
• W2022098162 hasAuthorship W2022098162A5029269873 @default.
• W2022098162 hasAuthorship W2022098162A5032518609 @default.
• W2022098162 hasAuthorship W2022098162A5042516416 @default.
• W2022098162 hasAuthorship W2022098162A5043350291 @default.
• W2022098162 hasConcept C118552586 @default.
• W2022098162 hasConcept C126322002 @default.
• W2022098162 hasConcept C141071460 @default.
• W2022098162 hasConcept C156957248 @default.
• W2022098162 hasConcept C168563851 @default.
• W2022098162 hasConcept C2776541429 @default.
• W2022098162 hasConcept C2778231337 @default.
• W2022098162 hasConcept C2779386548 @default.
• W2022098162 hasConcept C2780775167 @default.
• W2022098162 hasConcept C44249647 @default.
• W2022098162 hasConcept C509974204 @default.
• W2022098162 hasConcept C71924100 @default.
• W2022098162 hasConcept C95190672 @default.
• W2022098162 hasConceptScore W2022098162C118552586 @default.
• W2022098162 hasConceptScore W2022098162C126322002 @default.
• W2022098162 hasConceptScore W2022098162C141071460 @default.

• next